|Age||Total Calculated Compensation||This person is connected to 150 board members in 7 different organizations across 6 different industries.|
See Board Relationships
Mr. Daniel Tassé serves as the Chairman and Chief Executive Officer of Alcresta Therapeutics, Inc. Mr. Tassé serves as Senior Advisor at Bridge Growth Partners, LLC. An accomplished healthcare executive, he has built and led businesses with global footprints in the fields of bio-pharmaceuticals, medical devices, diagnostics and health services. He has more than 20 years of biopharmaceutical leadership experience. He served as the Chairman of the Board of Ikaria, Inc. ...
Perryville III Corporate ParkPhone: 908-238-6600
Hampton, New Jersey 08827-9001
Board Members Memberships*
Chairman and Chief Executive Officer
Senior Independent Director, Member of Audit Committee and Member of Nomination & Governance Committee
Independent Director and Member of Compensation Committee
Universite De Montreal, L'
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.